1-20 of 43
Min Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Li Ye, Ye Yang, Xuewu Zhang, Lu Wang, Li Zhu, Xia Li, Yile Zhou, Xiaolong Zheng, Xinping Zhou, Yanling Ren, Liya Ma, Gaixiang Xu, Chunmei Yang, Huafeng Wang, De Zhou, Min Yang, Xingnong Ye, Juying Wei, Wen-Juan Yu, Jiejing Qian, Yinjun Lou, Wanzhuo Xie, Jian Huang, Haitao Meng, Jie Jin, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 5384.
https://doi.org/10.1182/blood-2023-184470
Published: 2023
Journal Articles

High Grade B-Cell Lymphoma with 11q Aberration Is Not a Rare Event in HIV-Associated Lymphoma

Amy Chadburn, Paul Rubinstein, Ethel Cesarman, Swarna Gogineni, MIn Yang, Maneeza Bilal, Nadine Demko, Ivo N. Sah Bander, Chandler Sy, Victoria Alagiozian-Angelova, Liming Bao
Journal: Blood
Blood (2023) 142 (Supplement 1): 3121.
https://doi.org/10.1182/blood-2023-190635
Published: 2023
Journal Articles

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Ping Li, Wen-Juan Yu, Lili Zhou, Min Yang, Shiguang Ye, Judy Zhu, Jiaqi Huang, Yan Zhang, Lanfang Li, Jing Zhao, Kevin Zhu, Jing Li, Chengxiao Zheng, Liping Lan, Hui Wan, Yihong Yao, Huilai Zhang, Daobin Zhou, Jie Jin, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1025.
https://doi.org/10.1182/blood-2023-182817
Published: 2023
Journal Articles

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

Feng Zhu, Nianci Chen, Yile Zhou, Yi Zhang, Jian Huang, Wanzhuo Xie, Haitao Meng, Wen-Juan Yu, Liping Mao, Wenyuan MAI, Chunmei Yang, Juying Wei, Yinjun Lou, Min Yang, Jiejing Qian, Gaixiang Xu, De Zhou, Liya Ma, Xingnong Ye, Yanling Ren, Hongyan Tong, Huafeng Wang, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6001.
https://doi.org/10.1182/blood-2023-186048
Published: 2023
Journal Articles

Venetoclax Plus ‘2 + 5‘ Modified Intensive Chemotherapy with Daunorubicin and Cytarabine in Fit Elderly Patients with Untreated De Novo Acute Myeloid Leukaemia: A Single-Centre Retrospective Analysis

Jiajia Pan, Huafeng Wang, Liping Mao, Yinjun Lou, Yanling Ren, Xingnong Ye, Honghu Zhu, Min Yang, Jiejing Qian, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 2912.
https://doi.org/10.1182/blood-2023-180770
Published: 2023
Journal Articles

Dual CK1ε/PI3Kδ Inhibitor HZ-H08905, Exhibits As a Potential Therapeutic Strategy for Hematologic Malignancies

Juying Wei, Wenjuan Yu, Hongyan Tong, Min Yang, Miao Hu, Xingguo Liu, Yizhe Wu, Xinglu Zhou, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 12065.
https://doi.org/10.1182/blood-2022-165195
Published: 2022
Journal Articles

Clinical Features and Outcomes of Polycythemia Vera Patients with Different JAK2 V617F Mutational Status and Allele Burden

Lan Zhang, Keyi Jin, Min Yang, Xiaoqiong Zhu, Jian Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12286–12287.
https://doi.org/10.1182/blood-2022-166253
Published: 2022
Journal Articles

Homoharringtonine Synergizes Strongly with Venetoclax Against the Early T-Cell Progenitor Acute Lymphoblastic Leukemia：from Bench to Bed

Shanshan Suo, Shu SUN, Jiejing Qian, Dandan Zhao, Wenjuan Yu, Yinjun Lou, Honghu Zhu, Hongyan Tong, Min Yang, Xin Huang, Shuqi Zhao, Junjing Qiao, Chen Liang, Fenglin Li, Huafeng Wang, Yi Zhang, Le Xuan Truong Nguyen, Dinh Hoa Hoang, Fang Chen, Jie Sun, Ivan Rodriguez, Lucy Ghoda, Ling Li, Bin Zhang, Guido Marcucci, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 2263–2264.
https://doi.org/10.1182/blood-2022-170604
Published: 2022
Journal Articles

The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Jianai Sun, Yi Xu, Min Yang, Huafeng Wang, Wenjuan Yu, Liangshun You, Haitao Meng, Chunmei Yang, Xinping Zhou, Li Li, De Zhou, Xiujing Ye, Hong-hu Zhu, Hongyan Tong, Jie Jin, Wanzhuo Xie
Journal: Blood
Blood (2022) 140 (Supplement 1): 3756.
https://doi.org/10.1182/blood-2022-158723
Published: 2022
Journal Articles

Simultaneous Inhibition of SIRT3 and Cholesterol Homeostasis Targets AML Stem Cells By Perturbing Fatty Acid β-Oxidation and Inducing Lipotoxicity

Cristiana O'Brien, Tianyi Ling, Jacob Berman, Rachel Culp-Hill, Julie A. Reisz, Vincent Rondeau, Soheil Jahangiri, Jonathan St-Germain, Vinitha Macwan, Audrey Astori, Andy G.X. Zeng, Jun Young Hong, Meng Li, Min Yang, Sadhan Jana, John E. Dick, Hening Lin, Ari Melnick, Anastasia N Tikhonova, Andrea Arruda, Mark D. Minden, Brian Raught, Angelo D'Alessandro, Courtney L Jones
Journal: Blood
Blood (2022) 140 (Supplement 1): 104–106.
https://doi.org/10.1182/blood-2022-157794
Published: 2022
Journal Articles

Clinical Features and Outcomes of Pre-Fibrotic Primary Myelofibrosis Patients with Triple-Negative, JAK2V617F and Calr Mutations

Shiwei Hu, Danhong Xiang, Min Yang, Jian Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3957–3958.
https://doi.org/10.1182/blood-2022-165004
Published: 2022
Journal Articles

Venetoclax Plus "2 + 5" Modified Intensive Chemotherapy with Daunorubicin and Cytarabine in Fit Elderly Patients with Untreated De Novo Acute Myeloid Leukemia: A Single-Center Retrospective Analysis

Huafeng Wang, Yiyi Yao, Liping Mao, Yinjun Lou, Yanling Ren, Xingnong Ye, Min Yang, Liya Ma, Yi Zhang, Yile Zhou, Xin Huang, Yungui Wang, Huan Xu, Hongyan Tong, Hong-hu Zhu, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 3350–3351.
https://doi.org/10.1182/blood-2022-165738
Published: 2022
Journal Articles

A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia

Jiejing Qian, Jieyu Xu, Qing Hong, Yinjun Lou, Liping Mao, Weilai Xu, Min Yang, Wenjuan Yu, Haitao Meng, Wenyuan Mai, Xiujing Ye, Honghu Zhu, Jie Jin
Journal: Blood
Blood (2021) 138 (Supplement 1): 4414.
https://doi.org/10.1182/blood-2021-149523
Published: 2021
Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia

Huafeng Wang, Liping Mao, Wanzhuo Xie, Hongyan Tong, Min Yang, Gaixiang Xu, Xiujin Ye, Ying Lu, Juying Wei, Wenyuan Mai, De Zhou, Jie Jin, Hong-Hu Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2334.
https://doi.org/10.1182/blood-2021-153257
Published: 2021
Journal Articles

Sirtuin 3 Inhibition Targets AML Stem Cells through Perturbation of Fatty Acid Oxidation

Cristiana O'Brien, Jacob Berman, Rachel Culp-Hill, Julie Reisz, Tianyi Ling, Vincent Rondeau, Meng Li, Min Yang, Jun Young Hong, Hening Lin, Ari Melnick, Andrea Arruda, Mark D. Minden, Angelo D'Alessandro, Courtney L Jones
Journal: Blood
Blood (2021) 138 (Supplement 1): 2240.
https://doi.org/10.1182/blood-2021-148143
Published: 2021
Journal Articles

Integrated Analysis of B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Relapsed and Refractory Multiple Myeloma Subjects By High-Risk Factors

Chengcheng Fu, Songfu Jiang, Jie Jin, Wenming Chen, Siguo Hao, Zhen Cai, Zonghai LI, Lingzhi Yan, Kang Yu, Min Yang, Huijuan Wang, Wenhao Zhang, Xiaoyan Han, Wei Wang, Hongxia Zhao
Journal: Blood
Blood (2021) 138 (Supplement 1): 1751.
https://doi.org/10.1182/blood-2021-151935
Published: 2021
Journal Articles

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within AML1-ETO-Positive Acute Myeloid Leukemia

Min Yang, MD PhD, Yi Zhang, MDcal Master, Jinghan Wang, MDPhD, Lixia Liu, Chengcheng Wang, Feng Lou, Shanbo Cao, Jie Jin, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-142100
Published: 2020
Journal Articles

Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma

Siguo Hao, MD PhD, Jie Jin, MD PhD, Songfu Jiang, MD, Zonghai Li, MD PhD, Wenhao Zhang, MD PhD, Min Yang, MD PhD, Kang Yu, MD, Wei Wang, MDPhD, Linjun Chen, MD PhD, Haitao Meng, MD PhD, Mingxia He, MD, Jun Xiao, MD, Rong Tao, MD PhD, Xin Huang, MD PhD, Chongyun Xing, MD, Daijing Yuan, MD, Jianbo Wan, MD PhD, Shasha Wang, MD PhD, Lihui Dai, BS, Hong Ma, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-140156
Published: 2020
Journal Articles

Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma

Jin Jie, MD PhD, Siguo Hao, MD PhD, Songfu Jiang, MD, Zonghai Li, MD PhD, Min Yang, MD PhD, Wenhao Zhang, MD PhD, Kang Yu, MD, Jun Xiao, MD, Haitao Meng, MD PhD, Liyuan Ma, MD PhD, Mingxia He, MD, Wei WANG, MD PhD, Xin Huang, MD PhD, Linjun Chen, MD PhD, Chongyun Xing, MD, Daijing Yuan, MD, Shasha Wang, MD PhD, Rong Tao, MD PhD, Lihui Dai, BS, Hong Ma, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4435.
https://doi.org/10.1182/blood-2019-126104
Published: 2019
Journal Articles

Low Dose of Human scFv-Derived BCMA-Targeted CAR-T Cells Achieved Fast Response and High Complete Remission in Patients with Relapsed/Refractory Multiple Myeloma

Songfu Jiang, MD, Jie Jin, MD PhD, Siguo Hao, MD PhD, Min Yang, MD, Linjun Chen, MD, Huaying Ruan, MS, Jun Xiao, MD, Wei Wang, MD PhD, Zonghai Li, MD PhD, Kang Yu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 960.
https://doi.org/10.1182/blood-2018-99-113220
Published: 2018